| Gene symbol | TNFRSF13C | Synonyms | BAFF-R, BAFFR, BROMIX, CD268, CVID4, prolixin | Type of gene | protein-coding |
| Chromosome | 22 | Map location | 22q13.2 | dbXrefs | |
| Description | TNF receptor superfamily member 13C | ||||
| GTO ID | GTC3026 |
| Trial ID | NCT05370430 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | BAFFR |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BAFFR CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL |
| Year | 2022 |
| Country | United States |
| Company sponsor | PeproMene Bio, Inc. |
| Other ID(s) | PMB-102|PMB-BAFFR-102 |
| Cohort 1 | |||||||
|
|||||||